4//SEC Filing
RA Capital Healthcare Fund LP 4
Accession 0001231919-25-000596
CIK 0001680581other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:42 PM ET
Size
15.1 KB
Accession
0001231919-25-000596
Insider Transaction Report
Form 4
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-12-08$13.33/sh−1,377,020$18,355,677→ 8,852,079 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.28/sh−2,706,397$38,647,349→ 6,145,682 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.98/sh−91,722$1,373,996→ 6,053,960 total(indirect: See footnotes)
RA Capital Healthcare Fund LP
10% Owner
Transactions
- Sale
Common Stock
2025-12-08$13.33/sh−1,377,020$18,355,677→ 8,852,079 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.28/sh−2,706,397$38,647,349→ 6,145,682 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.98/sh−91,722$1,373,996→ 6,053,960 total(indirect: See footnotes)
Kolchinsky Peter
10% Owner
Transactions
- Sale
Common Stock
2025-12-08$13.33/sh−1,377,020$18,355,677→ 8,852,079 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.28/sh−2,706,397$38,647,349→ 6,145,682 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.98/sh−91,722$1,373,996→ 6,053,960 total(indirect: See footnotes)
Shah Rajeev M.
10% Owner
Transactions
- Sale
Common Stock
2025-12-08$13.33/sh−1,377,020$18,355,677→ 8,852,079 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.28/sh−2,706,397$38,647,349→ 6,145,682 total(indirect: See footnotes) - Sale
Common Stock
2025-12-08$14.98/sh−91,722$1,373,996→ 6,053,960 total(indirect: See footnotes)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $13.8099 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- [F3]Held directly by the Fund.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.81 to $14.805 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.81 to $15.39 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001315082
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:42 PM ET
- Size
- 15.1 KB